Circle Pharma

company

About

Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$4.50M
Industries
Biotechnology,Clinical Trials,Health Care,Therapeutics
Founded date
Jan 1, 2012
Number Of Employee
11 - 50
Operating Status
Active

Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$72.50M
Circle Pharma has raised a total of $72.50M in funding over 2 rounds. Their latest funding was raised on Jun 16, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 16, 2021 Series C $66M 1 Detail
Apr 25, 2017 Series A $2M 1 Detail
Dec 21, 2016 Series A $4.50M 1 Detail
Sep 22, 2014 Seed 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Circle Pharma is funded by 3 investors. Hartford HealthCare Endowment and Whitesun Healthcare Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Hartford HealthCare Endowment Series C
Whitesun Healthcare Ventures Series A
Pfizer Series A